各号一覧

The 16th bristol-myers squibb Nagoya international cancer treatment symposium, "Hematologic mailgnancies : Pioneers in cancer therapy across the century from mustard to molecular targets and beyond"

Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis

Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl]-N-(2.2.3.3.3-pentafluoropropyl) acetamide] in human patients : Implications for hypoxia measurements in vivo by 2-nitroimidazoles

Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesothelioma

Antitumoral activity of a sulphur-containing platinum complex with an acidic pH optimum

Human plasma carboxylesterase and butyrylcholinesterase enzyme activity : correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

Pharmacokinetics, distribution, metabolism and excretion of [3H] UCN-01 in rats and dogs after intravenous administration

The 15th bristol-Myers squibb Nagoya international cancer treatment symposium "New immunological approach to cancer treatment"

Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes

Phase I dose escalation pharmacokinetics of 0-(chloroacetylcarbamoyl) tumagillol (TNP-470) and its metabolites in AIDS patients with kaposi's sarcoma

A novel synthetic DNA minor groove binder, MS-247 : Antitumor activity and cytotoxic mechanism

Modulation of plasma uridine concentration by 5-(phenylselenenyl) acyclouridine, an inhibitor of uridine phosphorylase : Relevance to chemotherapy

Tumor apoptosis induced by epxide-containing piperazines, a new class of anti-cancer agents

Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines

The plasma pharmacokinetics and cerebraspinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model